an interview with
Michael T. Trese, MD, FASRS
In this interview with one of retina’s true giants, Mike Trese, MD, FASRS, details his remarkable 45-year career spearheading revolutionary developments in both pediatric and adult retina. He shares the challenges of navigating blinding diseases with the youngest and most vulnerable patients and the amazing advances that have increased the success rate for retinopathy of prematurity (ROP) from 50% to 90%. He also touches on his strong desire to make a contribution to the field and to his patients that has spawned the development of key innovations in retinal instrumentation and surgery.